<DOC>
	<DOCNO>NCT01298271</DOCNO>
	<brief_summary>Design randomize trial compare effect endoscopic cyanoacrylate injection obliteration versus non-selective beta-blocker primary prevention gastric variceal bleeding .</brief_summary>
	<brief_title>Primary Prevention Gastric Variceal Bleeding : Endoscopic Treatment Versus Non-selective Beta-blocker</brief_title>
	<detailed_description>Up date , treatment gastric variceal bleeding ( GVB ) still sub-optimal contrast treatment esophageal variceal bleeding ( EVB ) , already big improvement prognosis recent two decade . Gastric varix ( GV ) rarely rupture . However occur , outcome would worse rupture esophageal varies ( EV ) . Rupture GV characteristic high rebleeding rate ( 90 % ) , requirement large amount blood transfusion high mortality ( 40-50 % ) . Therefore , primary prevention GV rupture critically important . The management GV focus treatment acute GVB . Tissue adhesive ( cyanoacrylate ) may polymerize occlude vascular channel second obliterate 70 % case GV . The rebleeding rate endoscopic cyanoacrylate injection ( GVO ) acute GVB around 30~40 % expertise require reduce embolic complication instrumental injuries.GVO may arrest 90 % active GVB . The 2005 Baveno IV International Consensus 2007 AASLD Guidelines endorse endoscopic cyanoacrylate injection first line treatment acute GVB . However , efficacy prevention first GV bleed know . Non-selective beta-blocker ( NSBB ) effective prevent first second bleed esophageal varix . The 2005 Baveno IV International Consensus 2007 AASLD Guidelines also endorse NSBB first choice primary prevention EVB . However , effect gastric variceal hemorrhage never clarify . Actually , GV usually large gastrorenal shunting portal pressure GV low EV . For ethical concern , NSBB usually use primary prevention GVB , preventive effect NSBB never prove . Study primary prevention GVB scanty . This important issue prompt current portal hypertension expert . The investigator lot experience treatment gastric variceal bleed publish fruitful result high ranking journal . Therefore , investigator design randomize trial compare effect endoscopic cyanoacrylate injection obliteration versus non-selective beta-blocker primary prevention gastric variceal bleeding .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>1. patient live cirrhosis and/or hepatoma 2 . Aged 18 80 , endoscopyProven EV ( ) GV ( + ) EV &lt; GV 1 . Patients previous endoscopic , surgical treatment Transjugular Intrahepatic Portosystemic Shunt 2 . Had terminal illness major organ system , heart failure , kindey failure , COPD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>gastric variceal bleeding</keyword>
	<keyword>primaryprevention</keyword>
	<keyword>cyanoacrylate injection</keyword>
	<keyword>non-selective beta-blocker</keyword>
</DOC>